pSivida Announces Positive Top Line Results From Investigator-Sponsored Phase II Study of Medidur™ for Uveitis
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces top line results from investigator-sponsored Phase II study of Medidur for uveitis. Statistically significant reduction in recurrence of disease and visual acuity.
